Business Wire

BrightSign Powers Intelligent Signage Experiences at ISE 2026

30.1.2026 10:00:00 EET | Business Wire | Press release

Share

With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026.

BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem.

“In today’s immersive, personalized and visual world, the stakes have never been higher for powerful, secure, reliable, and intelligent digital signage,” said Steve Durkee, chief executive officer of BrightSign. “When supported by the right AI, managed services, and CMS partner ecosystems, digital signage unlocks incredible opportunity. Organizations can turn every visual touchpoint into an intelligent, dynamic driver of business, revenue, and experience in more ways than ever before.”

At ISE 2026, BrightSign will showcase:

  • AI at the Edge: The demand for increasingly intelligent digital signage is rising as organizations face pressure to deliver exceptional customer experiences that adapt in real time, deliver measurable engagement, and support data-driven decision-making. BrightSign brings intelligence to digital signage with built-in Neural Processing Units (NPUs) that can run powerful AI applications directly on the player. Real-time motion, object and gaze detection, and audience measurement applications power interactive, personalized experiences that adapt to audience behavior. By powering AI applications directly on the player, BrightSign gives users access to real-time, privacy-forward intelligence, and real-world responsiveness without impacting video and audio performance. Integration with trusted CMS and analytics partners means users can easily build AI-powered applications to run on BrightSign players.
  • BrightSign Series 6: Series 6 – including the BrightSign XD6, HD6, and XS6 – represents the latest in digital signage media players, offering increased performance and flexibility while embodying the versatility and reliability synonymous with BrightSign. Industries need digital signage that supports strong performance, security, and reliability. Designed in response to this need, Series 6 offers smooth 4K and dual-4K playback, immersive graphics, integrated NPUs to run powerful AI applications, and secure BrightSignOS operation with purpose-built hardware engineered for uptime in demanding commercial environments. The series supports BrightSign’s 5-Year Warranty, adding another layer of confidence while protecting long-term investments.
  • Bright Alliance: Visitors can explore Bright Alliance, including exclusive partnerships with leading CMS providers, product integrations, expanded experiences, and collaborative support options.

In addition, Sharp (Booth #3E500) will showcase the new Sharp SDM Player with BrightSign Built-In System-on-a-Chip (SoC) solution. The all-in-one solution – available in Q2 of 2026 – combines the power of Sharp’s world-class professional Large Format Displays (LFD) with the high-performance, superior security, and CMS compatibility of BrightSign Built-In running BrightSignOS.

For more information on BrightSign’s presence at ISE, please visit: https://www.brightsign.biz/ise-tech-show.

About BrightSign

BrightSign LLC, the global market leader in digital signage media players, is headquartered in San Jose, California, with offices in Europe and Asia. BrightSign manufactures media players and provides free software and networking solutions for the commercial digital signage market worldwide, serving all vertical segments of the digital signage marketplace. From entry-level BrightSign LS players to BrightSign XC players offering state-of-the-art technology and unsurpassed performance, BrightSign’s products are known for their signature reliability, affordability, ease-of-use, and market-leading technology. For more information, visit BrightSign.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260130940454/en/

Contacts

Brightsign@racepointglobal.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 09:30:00 EET | Press release

Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, supported by one of the largest bodies of published clinical data backed by decades of clinica

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 09:00:00 EET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

Galderma Tackles Menopause-related Skin Changes With Global Survey and Clinical Trial Inclusivity30.1.2026 08:00:00 EET | Press release

Galderma (SIX: GALD) has unveiled findings from a global survey of peri- and post-menopausal women from nine countries exploring the impact of menopause on the skin at the International Master Course on Aging Science (IMCAS) 2026 World Congress in Paris, France, from January 29-31, 2026. The survey found that over 50% of women learned about the effects of menopause on the skin by going through it themselves, with most finding out about it in their 40s.2 However, over 30% would have liked to learn about this in their 30s and over 50% are at best neutral or dissatisfied with their knowledge on the topic.2 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260129610958/en/ To address this knowledge gap, Galderma will leverage its expertise in dermatology to advance awareness, understanding, education, and treatment approaches for menopause-related skin changes. With around 85% of aesthetic patients being female, it is important to

Convera Appoints Industry Leader Meaghan Riley as Chief Commercial Officer to Scale Commercial Growth and Expand Revenue Opportunities29.1.2026 18:14:00 EET | Press release

Convera, a global leader in commercial payments, today announces the appointment of Meaghan Riley to Chief Commercial Officer, as the company continues its growth trajectory, expands to new markets, and drives scalable revenue opportunities across geographies and sectors. Prior to Convera, Meaghan was Chief Operating Officer for Google Cloud North America, where she led a major go-to-market transformation and launched high-growth segments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260129799440/en/ Meaghan Riley, Chief Commercial Officer, Convera “Meaghan’s impressive career journey and proven track record brings exceptional experience and unique assets that will strengthen our leadership team at this pivotal moment in Convera’s journey,” said Patrick Gauthier, CEO, Convera. “Meaghan’s leadership will be instrumental in delivering on our commitment to make global business payments simpler and smarter—serving our customer

New Year, New Solutions: AMRA Medical Continues Commitment to Innovation & Data-Driven Excellence29.1.2026 17:23:00 EET | Press release

AMRA Medical, the global leader in MRI-based fat distribution and muscle composition analytics, is excited to share our brand repositioning supported by the launch of a refreshed website and the introduction of a new tagline, “Insights Within.” This strategic update reflects AMRA’s commitment to placing clients and collaborators at the center of our vision: to be the most trusted, insights-driven imaging partner in the pursuit of preventing and curing disease. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260129457626/en/ The new website provides a more structured and transparent presentation of AMRA’s biomarkers and research services, enabling our partners to have a clear understanding of our offerings, as well as the scientific value and applications of these solutions. For the first time, we’re introducing Imaging Biomarkers and Insights Biomarkers: clearly-defined, intentional offerings that are designed with your trial

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye